4//SEC Filing
Daniel Mark James 4
Accession 0001193125-25-245114
CIK 0001488039other
Filed
Oct 20, 8:00 PM ET
Accepted
Oct 21, 4:10 PM ET
Size
5.5 KB
Accession
0001193125-25-245114
Insider Transaction Report
Form 4
Daniel Mark James
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2025-10-14+578,000→ 578,000 totalExercise: $1.03Exp: 2035-10-14→ Common Stock (578,000 underlying)
Footnotes (1)
- [F1]The options shall vest with respect to 25% on October 14, 2026, with the remaining 75% to vest in equal quarterly installments over the follwing three years, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.
Documents
Issuer
ATOSSA THERAPEUTICS, INC.
CIK 0001488039
Entity typeother
Related Parties
1- filerCIK 0002092593
Filing Metadata
- Form type
- 4
- Filed
- Oct 20, 8:00 PM ET
- Accepted
- Oct 21, 4:10 PM ET
- Size
- 5.5 KB